American Academy of Optometry

Sedgwick said that with the recent FDA authorization of Stellest lenses, he expects SightGlass to eventually find its niche in the US.

Jacqueline Theis, OD, FAAO, reminds eye care providers that all dry eye is neurological.

Pamela Theriot, OD, FAAO, said that eye care providers should aim to maintain optimal vision throughout their lifetime through proactive, comprehensive care.

Joseph Allen, OD, FAAO, Dipl ABO, detailed treatments for macular degeneration, ocular surface disease, dry eye, and potential myopia management during his presentation.

Discover how a new dry eye treatment offers rapid relief and long-term benefits for patients, transforming treatment approaches in eye care.

Julie Rodman, OD, MS, FAAO, details the complexities and nuances of diabetic retinopathy cases.

Chang discusses innovative approaches to fitting irregular corneas, enhancing vision for keratoconus patients through advanced scleral lens techniques.

Michelle Chung, OD, FAAO, FSLS, highlights the subtle signs of this progressive eye condition and the importance of differential diagnosis to prevent long-term vision loss.

Young explores the complex relationship between recreational drug use and eye health, highlighting addiction's impact on vision and patient care strategies.

Erin Rueff, OD, PhD, FAAO, details the best ways to stay up to date with dry eye developments and innovations.

Giovanna Olivares, OD, presented 2 posters on new data concerning the Acuvue Oasys Max 1-Day for Astigmatism contact lenses at the conference.

Contact Lens Institute (CLI) Visionary Shelby Brogdon, OD, breaks down recent CLI research and what it means for patient education and care.

Justin Schweitzer, OD, FAAO, details his presentation on dry eye innovations at the conference.

Raman Bhakhri, OD, FAAO, states that even if the statistics are normally against the chance of a life-threatening condition, the margins for error are slim.

Julie Rodman, OD, MS, FAAO, highlighted the critical role of advanced imaging technologies in eye care practices during an AAOpt 2025 presentation.

Raman Bhakhri, OD, FAAO, gives tips for identifying the root cause of optic neuritis.

Rueff, OD, PhD, FAAO, stated during her presentation that optometrists are not taking full advantage of their opportunities to suggest contact lenses to their patients with presbyopia.

Johnson & Johnson has announced new data on its Acuvue Oasys Max 1-Day for Astigmatism contact lenses that demonstrated higher end-of-day comfort when compared to Dailies Total1 for Astigmatism.

New interim data demonstrate that more than half of children wearing DOT lenses experienced no clinically meaningful myopia progression over 18 months.

Jeffrey Walline, OD, PhD, said that the growing amount of CE sessions available is what sets the annual Academy meeting apart from other conferences.

Keeping an eye on CE, industry news, and collaboration in Boston, Massachusetts.

Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO, will be joined by a handful of colleagues to discuss the latest in retina in Boston, Massachusetts, from October 8 to 11.

A contact lens unveiling, geographic atrophy management, and an eventful Merton C Flom Leadership Academy luncheon took center stage at last month's conference.

Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.

Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been recommending the NutriTears supplement to their dry eye patients.

Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.

Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.

Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent study that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.

Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.